Evidence map›Paper›PMID 37445586›Full record

ArticleJournal of clinical medicine2023

MicroRNA-27b Impairs Nrf2-Mediated Angiogenesis in the Progression of Diabetic Foot Ulcer.

Shukla Sakshi, Ravichandran Jayasuriya, Rajappan Chandra Sathish Kumar, Dhamodharan Umapathy, Athira Gopinathan, Ramachandran Balamurugan, Kumar Ganesan, Kunka Mohanram Ramkumar

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Shukla SakshiDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur 603 203, Tamil Nadu, India.
Ravichandran JayasuriyaDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur 603 203, Tamil Nadu, India.
Rajappan Chandra Sathish KumarInterdisciplinary Institute of Indian System and Medicine (IIISM), SRM Institute of Science and Technology, Kattankulathur 603 203, Tamil Nadu, India.
Dhamodharan UmapathyDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur 603 203, Tamil Nadu, India.
Athira GopinathanSRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur 603 203, Tamil Nadu, India.
Ramachandran BalamuruganSRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur 603 203, Tamil Nadu, India.
Kumar GanesanSchool of Chinese Medicine, LKS Faculty of Medicine, University of Hong Kong, Hong Kong 999077, China.ORCID 0000-0002-3198-6066
Kunka Mohanram RamkumarDepartment of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur 603 203, Tamil Nadu, India.ORCID 0000-0001-5450-902X
SRM Institute of Science and Technology · INChinese University of Hong Kong · HK

Funding

Indian Council of Medical Research (ICMR), Government of India 2020-9621: 5/4/5-1/GIA-Endo/21-NCD-III
6 · The paper itself

Abstract

Nuclear factor erythroid-2-related factor 2 (

Indexed as

DFUendothelial cellsimpaired angiogenesismicroRNA-27bNrf2

Identifiers

PMID37445586
PMCPMC10342788
OpenAlexW4383736007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.